Accordingly, we aimed to determine the optimal dose of letrozole for prenatal PCOS induction in female rats by assessing the reproductive, endocrine PCOS phenotypes and the hypothalamus-pituitary-gonad (HPG) axis alterations via evaluation of mRNA expression of GnRH and RFRP genes. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.